Announcing the Empowered Antibodies 2013 Event
Friday, 14 May 2013
The Stevenage Bioscience Catalyst, within the GSK complex, Stevenage, UK
The aim of this event is to discuss new ideas to accelerate antibody-drug conjugates, bispecifics and other empowered antibody therapies to the clinic.
This event is part of the 2013 Euroscicon BioTherapeutics Week,
to find out more see www.biotherapeutics2013.com
Speaker include
Professor Roy Jefferis, PhD; CChem, FRSC; MRCP; FRCPath; DSc
Professor Emeritus: Molecular Immunology School of Immunity & Infection University of Birmingham B15 2TT UK
Dr Mahendra Deonarain, Imperial College, London
Professor Phil Blower, Kings College London, UK
Dr Surinder K Sharma, Head: ADEPT & Translational Therapeutics, UCL Cancer Institute
Dr. Sandra Diebold, Guy’s Hospital London
Dr Mahendra Deonarain, Imperial College
Phone: (+44) 07507 799380
The Stevenage Bioscience Catalyst campus is a unique bioscience community created to provide small biotech and life sciences companies and start-ups with access to the expertise, networks and scientific facilities traditionally associated with multinational pharmaceutical companies
Tags: antibody, Antibody Discovery, Antibody Engineering, Biologics, Business Development Genomics, Discovery Chemistry, Formulation Development, Immunoassay, Molecular Biology and Chemistry, Molecular Discovery Research, Molecular Medicine, monoclonal antibody, nuclear medicine, PET, Protein Engineering, radionuclide therapy, radionuclides, Regulatory Affairs, SPECT, Translational Research
Follow Us!